US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

263.04

+15.136.10%

Post-market: 264.251.21+0.46%19:30 EDT

Volume:1.03M

Turnover:270.01M

Market Cap:17.41B

PE:20.30

High:268.98

Open:247.65

Low:247.65

Close:247.91

52wk High:282.15

52wk Low:186.05

Shares:66.19M

Float Shares:65.54M

Volume Ratio:3.65

T/O Rate:1.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):12.96

EPS(LYR):-4.4176

ROE:118.78%

ROA:9.58%

PB:10.45

PE(LYR):-59.54

Loading ...

Overview Company News Filings

Ascendis Pharma reports new radiographic data from Week 104 from ApproaCH Trial

Ascendis Says Transcon CNP Achondroplasia Trial Shows Continued Leg-alignment Gains at Week 104

Ascendis Pharma Added to Multiple Russell Indexes

MT Newswires Live

Ascendis Pharma Reports Week 104 Approach Trial Data Showing Improved Leg Alignment with Transcon CNP in Achondroplasia

Movement Alert｜Ascendis Pharma Rises 8.3% in Regular Trading, Core Drug Long-Term Clinical Data Impresses as Analysts Reiterate Bullish Stance

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)

Ascendis Pharma sells priority review voucher for $187.5 million cash

Ascendis Pharma (ASND) Receives a Buy from Wells Fargo

Analysts’ Top Healthcare Picks: Amylyx Pharmaceuticals Inc (AMLX), Ascendis Pharma (ASND)

Ascendis Pharma's Yorvipath Has Superior Profile Relative to Competitors, Wedbush Says

MT Newswires Live

Ascendis reports sustained efficacy, safety for TransCon PTH in PaTHway hypoparathyroidism trial at Week 182

Ascendis Pharma completes Phase 3 PaTHway Trial

Ascendis says Phase 3 PaTHway trial shows TransCon PTH sustains hypoparathyroidism benefits through Week 182

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

MBX's Flagship Drug Trial Met Expectations But Perhaps Some Investors Wanted More -- Market Talk

European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week

MT Newswires Live

Ascendis says Phase 2 trial shows TransCon PTH sustains hypoparathyroidism benefits at 5 years

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer

Ascendis presents final Phase 3 PaTHway results for palopegteriparatide in adult hypoparathyroidism at ENDO 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ASND/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASND\",,,,,undefined,":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":263.04,"timestamp":1788206400000,"preClose":247.91,"halted":0,"volume":1026166,"hourTrading":{"tag":"盘后","latestPrice":264.25,"preClose":263.04,"latestTime":"19:30 EDT","volume":56771,"amount":14933378.8312,"timestamp":1788219003345,"change":1.21,"changeRate":0.0046,"amplitude":0.0046},"delay":0,"changeRate":0.06103021257714503,"floatShares":65539518,"shares":66189926,"eps":12.96,"marketStatus":"Not Yet Opened","change":15.13,"latestTime":"08-31 16:00:00 EDT","open":247.65,"high":268.98,"low":247.65,"amount":270007927.7263,"amplitude":0.086039,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.96,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":1,"adrRate":1,"listingDate":1422421200000,"exchange":"NASDAQ","adjPreClose":247.91,"preHourTrading":{"tag":"盘前","latestPrice":249.36,"preClose":247.91,"latestTime":"09:20 EDT","volume":543,"amount":134692.48578,"timestamp":1788182446542,"change":1.45,"changeRate":0.005849,"amplitude":0.028962},"postHourTrading":{"tag":"盘后","latestPrice":264.25,"preClose":263.04,"latestTime":"19:30 EDT","volume":56771,"amount":14933378.8312,"timestamp":1788219003345,"change":1.21,"changeRate":0.0046,"amplitude":0.0046},"volumeRatio":3.65133,"impliedVol":0.3755,"impliedVolPercentile":0.0956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASND\",,,,,undefined,":{"symbol":"ASND","floatShares":65539518,"roa":"9.58%","roe":"118.78%","lyrEps":-4.417628,"volumeRatio":3.65133,"shares":66189926,"dividePrice":0,"high":268.98,"amplitude":0.086039,"preClose":247.91,"low":247.65,"week52Low":186.054,"pbRate":"10.45","psRate":"14.33","week52High":282.15,"institutionHeld":0,"latestPrice":263.04,"eps":12.96,"divideRate":0,"volume":1026166,"delay":0,"ttmEps":12.96,"open":247.65,"prevYearClose":213.24,"prevWeekClose":247.91,"prevMonthClose":243.91,"prevQuarterClose":266.72,"fiveDayClose":251.95,"twentyDayClose":243.45,"sixtyDayClose":218.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ASND","fiscalQuarterEnding":"2026/06","expectedEps":0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":3.29},{"market":"US","date":"2026-05-07","symbol":"ASND","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":0.32},{"market":"US","date":"2026-02-11","symbol":"ASND","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2025-11-12","symbol":"ASND","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-08-07","symbol":"ASND","fiscalQuarterEnding":"2025/06","expectedEps":-1.42,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASND\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.5455,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":22,"updateTime":1788062400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASND","date":"2026-08-28","current":20.296296,"percent":0.939641,"low":-57.338086,"twenty":-24.992741,"median":-14.645114,"eighty":-9.402009,"high":30.368413,"avg":-16.773981,"sd":16.598045,"marketCap":16376290098},"quantilePoints":[{"date":"2021-09-03","current":-17.310645,"twenty":-30.428706,"median":-21.352703,"eighty":-16.346413,"marketCap":9418965330},{"date":"2021-09-10","current":-16.189844,"twenty":-30.428706,"median":-21.319432,"eighty":-16.296107,"marketCap":8768483895},{"date":"2021-09-17","current":-17.080111,"twenty":-30.428706,"median":-21.230017,"eighty":-16.243102,"marketCap":9180073350},{"date":"2021-09-24","current":-17.386188,"twenty":-30.428706,"median":-21.183984,"eighty":-16.243102,"marketCap":9321602560},{"date":"2021-10-01","current":-17.373879,"twenty":-30.428706,"median":-21.123882,"eighty":-16.243102,"marketCap":9222134240},{"date":"2021-10-08","current":-18.157107,"twenty":-30.428706,"median":-21.000335,"eighty":-16.243102,"marketCap":9621144300},{"date":"2021-10-15","current":-17.131611,"twenty":-30.428706,"median":-20.927013,"eighty":-16.243102,"marketCap":9099866902},{"date":"2021-10-22","current":-15.443416,"twenty":-30.428706,"median":-20.767309,"eighty":-16.177661,"marketCap":8225087523},{"date":"2021-10-29","current":-16.287021,"twenty":-30.428706,"median":-20.694874,"eighty":-16.089869,"marketCap":8623231584},{"date":"2021-11-05","current":-17.273361,"twenty":-30.428706,"median":-20.628679,"eighty":-16.089869,"marketCap":9139112531},{"date":"2021-11-12","current":-18.536152,"twenty":-30.428706,"median":-20.572898,"eighty":-16.089869,"marketCap":8837935471},{"date":"2021-11-19","current":-17.902122,"twenty":-30.349178,"median":-20.47977,"eighty":-16.089869,"marketCap":8440932665},{"date":"2021-11-26","current":-17.30965,"twenty":-30.112548,"median":-20.45204,"eighty":-16.089869,"marketCap":8157885464},{"date":"2021-12-03","current":-16.362158,"twenty":-29.857189,"median":-20.380959,"eighty":-16.089869,"marketCap":7692190570},{"date":"2021-12-10","current":-16.853703,"twenty":-29.857189,"median":-20.300515,"eighty":-16.089869,"marketCap":7941204040},{"date":"2021-12-17","current":-16.000816,"twenty":-29.857189,"median":-20.212189,"eighty":-16.020012,"marketCap":7513834299},{"date":"2021-12-23","current":-16.77763,"twenty":-29.857189,"median":-20.155183,"eighty":-16.020012,"marketCap":7907148535},{"date":"2021-12-31","current":-16.120129,"twenty":-29.857189,"median":-20.049594,"eighty":-16.020012,"marketCap":7635290643},{"date":"2022-01-07","current":-14.042624,"twenty":-29.839892,"median":-19.980256,"eighty":-15.942334,"marketCap":6632424474},{"date":"2022-01-14","current":-14.670073,"twenty":-29.839892,"median":-19.920189,"eighty":-15.716079,"marketCap":6978631810},{"date":"2022-01-21","current":-12.972874,"twenty":-29.839892,"median":-19.876598,"eighty":-15.573671,"marketCap":6127869848},{"date":"2022-01-28","current":-14.62122,"twenty":-29.839892,"median":-19.786144,"eighty":-15.516247,"marketCap":6797014847},{"date":"2022-02-04","current":-14.50631,"twenty":-29.839892,"median":-19.652538,"eighty":-15.436915,"marketCap":6913363214},{"date":"2022-02-11","current":-14.677518,"twenty":-29.839892,"median":-19.581266,"eighty":-15.347041,"marketCap":6971821174},{"date":"2022-02-18","current":-13.466571,"twenty":-29.591943,"median":-19.485906,"eighty":-15.209144,"marketCap":6356026158},{"date":"2022-02-25","current":-13.12621,"twenty":-29.404171,"median":-19.414286,"eighty":-15.117707,"marketCap":6159085264},{"date":"2022-03-04","current":-14.177375,"twenty":-29.202227,"median":-19.36732,"eighty":-15.054328,"marketCap":5935510787},{"date":"2022-03-11","current":-13.816292,"twenty":-29.07162,"median":-19.272945,"eighty":-14.959346,"marketCap":5802071102},{"date":"2022-03-18","current":-15.716255,"twenty":-28.939908,"median":-19.217636,"eighty":-14.936745,"marketCap":6668577316},{"date":"2022-03-25","current":-15.411389,"twenty":-28.844885,"median":-19.190899,"eighty":-14.936745,"marketCap":6495389639},{"date":"2022-04-01","current":-15.559542,"twenty":-28.757451,"median":-19.17389,"eighty":-14.936745,"marketCap":6587508157},{"date":"2022-04-08","current":-15.122522,"twenty":-28.605231,"median":-19.072944,"eighty":-14.936745,"marketCap":6309170742},{"date":"2022-04-14","current":-15.463474,"twenty":-28.453115,"median":-19.041314,"eighty":-14.884459,"marketCap":6410281068},{"date":"2022-04-22","current":-14.551524,"twenty":-28.374507,"median":-19.004239,"eighty":-14.799315,"marketCap":6016632439},{"date":"2022-04-29","current":-12.825416,"twenty":-28.283885,"median":-18.934719,"eighty":-14.771755,"marketCap":5184460373},{"date":"2022-05-06","current":-11.613026,"twenty":-28.168362,"median":-18.891739,"eighty":-14.706803,"marketCap":4719239266},{"date":"2022-05-13","current":-9.984926,"twenty":-28.076589,"median":-18.864911,"eighty":-14.677978,"marketCap":4638391408},{"date":"2022-05-20","current":-11.307391,"twenty":-27.984173,"median":-18.790002,"eighty":-14.651461,"marketCap":5323659051},{"date":"2022-05-27","current":-10.362949,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4954797559},{"date":"2022-06-03","current":-10.068769,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4816206322},{"date":"2022-06-10","current":-9.837168,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4619763144},{"date":"2022-06-17","current":-10.029309,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4683383946},{"date":"2022-06-24","current":-10.798489,"twenty":-27.955811,"median":-18.747509,"eighty":-14.651385,"marketCap":5083525305},{"date":"2022-07-01","current":-11.133161,"twenty":-27.955811,"median":-18.747509,"eighty":-14.651385,"marketCap":5168026464},{"date":"2022-07-08","current":-11.501599,"twenty":-27.955811,"median":-18.747509,"eighty":-14.647791,"marketCap":5224394787},{"date":"2022-07-15","current":-10.574962,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":4762286157},{"date":"2022-07-22","current":-10.827381,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":4939762660},{"date":"2022-07-29","current":-10.48637,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":4773448202},{"date":"2022-08-05","current":-11.686251,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":5296948075},{"date":"2022-08-12","current":-15.258303,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":6151960660},{"date":"2022-08-19","current":-13.088553,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5167468362},{"date":"2022-08-26","current":-12.82393,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5040221058},{"date":"2022-09-02","current":-12.511949,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":4935855945},{"date":"2022-09-09","current":-14.33111,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5658040204},{"date":"2022-09-16","current":-15.212187,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":5995062260},{"date":"2022-09-23","current":-14.704326,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5621941828},{"date":"2022-09-30","current":-14.958022,"twenty":-27.955811,"median":-18.694608,"eighty":-14.619858,"marketCap":5767726907},{"date":"2022-10-07","current":-16.418696,"twenty":-27.955811,"median":-18.597682,"eighty":-14.611455,"marketCap":6311767776},{"date":"2022-10-14","current":-15.643642,"twenty":-27.955811,"median":-18.546958,"eighty":-14.611455,"marketCap":5995062260},{"date":"2022-10-21","current":-15.713995,"twenty":-27.955811,"median":-18.471013,"eighty":-14.611455,"marketCap":6060414192},{"date":"2022-10-28","current":-15.714051,"twenty":-27.955811,"median":-18.422988,"eighty":-14.589371,"marketCap":6144198720},{"date":"2022-11-04","current":-13.889878,"twenty":-27.955811,"median":-18.371607,"eighty":-14.551051,"marketCap":6634289132},{"date":"2022-11-11","current":-14.816192,"twenty":-27.955811,"median":-18.348112,"eighty":-14.537069,"marketCap":7373481023},{"date":"2022-11-18","current":-13.274499,"twenty":-27.955811,"median":-18.324877,"eighty":-14.513901,"marketCap":6628143167},{"date":"2022-11-25","current":-12.929127,"twenty":-27.955811,"median":-18.324877,"eighty":-14.492596,"marketCap":6477846403},{"date":"2022-12-02","current":-13.866632,"twenty":-27.955811,"median":-18.324877,"eighty":-14.463422,"marketCap":7005840612},{"date":"2022-12-09","current":-12.881379,"twenty":-27.955811,"median":-18.297625,"eighty":-14.39883,"marketCap":6540982219},{"date":"2022-12-16","current":-12.969963,"twenty":-27.955811,"median":-18.296547,"eighty":-14.350758,"marketCap":6626466995},{"date":"2022-12-23","current":-13.001454,"twenty":-27.955811,"median":-18.255178,"eighty":-14.328948,"marketCap":6653844473},{"date":"2022-12-30","current":-13.251203,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":6823696578},{"date":"2023-01-06","current":-13.88229,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":7099357725},{"date":"2023-01-13","current":-12.356383,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":6441387593},{"date":"2023-01-20","current":-13.193213,"twenty":-27.955811,"median":-18.15843,"eighty":-14.273409,"marketCap":6888807283},{"date":"2023-01-27","current":-13.114667,"twenty":-27.955811,"median":-18.15843,"eighty":-14.249518,"marketCap":6859688605},{"date":"2023-02-03","current":-12.433541,"twenty":-27.955811,"median":-18.15843,"eighty":-14.221956,"marketCap":6501304873},{"date":"2023-02-10","current":-12.400608,"twenty":-27.955811,"median":-18.15843,"eighty":-14.198427,"marketCap":6380910339},{"date":"2023-02-17","current":-10.511711,"twenty":-27.955811,"median":-18.15843,"eighty":-14.159248,"marketCap":6536966030},{"date":"2023-02-24","current":-10.326898,"twenty":-27.955811,"median":-18.146338,"eighty":-14.123953,"marketCap":6354278424},{"date":"2023-03-03","current":-10.345133,"twenty":-27.955811,"median":-18.097908,"eighty":-14.094932,"marketCap":6395186999},{"date":"2023-03-10","current":-9.568888,"twenty":-27.955811,"median":-18.039078,"eighty":-14.053275,"marketCap":5951917378},{"date":"2023-03-17","current":-9.777457,"twenty":-27.955811,"median":-18.011685,"eighty":-14.0184,"marketCap":6078407412},{"date":"2023-03-24","current":-9.398575,"twenty":-27.955811,"median":-17.994272,"eighty":-13.932842,"marketCap":5896291266},{"date":"2023-03-31","current":-9.5125,"twenty":-27.947426,"median":-17.969708,"eighty":-13.865667,"marketCap":6027414759},{"date":"2023-04-06","current":-6.283685,"twenty":-27.947426,"median":-17.969708,"eighty":-13.841688,"marketCap":4001974041},{"date":"2023-04-14","current":-7.201403,"twenty":-27.955811,"median":-17.976848,"eighty":-13.817394,"marketCap":4641705247},{"date":"2023-04-21","current":-7.296307,"twenty":-27.955811,"median":-17.962569,"eighty":-13.754676,"marketCap":4667283252},{"date":"2023-04-28","current":-6.732417,"twenty":-27.955811,"median":-17.962569,"eighty":-13.71092,"marketCap":4327461184},{"date":"2023-05-05","current":-8.446623,"twenty":-27.955811,"median":-17.931459,"eighty":-13.571569,"marketCap":5284809377},{"date":"2023-05-12","current":-8.682804,"twenty":-27.964197,"median":-17.903569,"eighty":-13.544525,"marketCap":5391056476},{"date":"2023-05-19","current":-8.205556,"twenty":-27.972582,"median":-17.84903,"eighty":-13.532291,"marketCap":5023969940},{"date":"2023-05-26","current":-8.154362,"twenty":-27.972582,"median":-17.804262,"eighty":-13.443227,"marketCap":4972813930},{"date":"2023-06-02","current":-8.099575,"twenty":-27.972582,"median":-17.774765,"eighty":-13.379358,"marketCap":4944706232},{"date":"2023-06-09","current":-8.461637,"twenty":-27.972582,"median":-17.75578,"eighty":-13.359333,"marketCap":5184108718},{"date":"2023-06-16","current":-8.368476,"twenty":-27.980967,"median":-17.74711,"eighty":-13.343143,"marketCap":5198163887},{"date":"2023-06-23","current":-8.017188,"twenty":-27.984173,"median":-17.75578,"eighty":-13.331596,"marketCap":4996331653},{"date":"2023-06-30","current":-7.946371,"twenty":-27.98738,"median":-17.764862,"eighty":-13.301445,"marketCap":4919309325},{"date":"2023-07-07","current":-7.891043,"twenty":-27.98738,"median":-17.74711,"eighty":-13.289443,"marketCap":4873915001},{"date":"2023-07-14","current":-7.732097,"twenty":-27.98738,"median":-17.724083,"eighty":-13.262449,"marketCap":4921141770},{"date":"2023-07-21","current":-7.989428,"twenty":-27.98738,"median":-17.643003,"eighty":-13.239605,"marketCap":5063384300},{"date":"2023-07-28","current":-7.876699,"twenty":-27.98738,"median":-17.643003,"eighty":-13.192293,"marketCap":4922266217},{"date":"2023-08-04","current":-8.517492,"twenty":-27.98738,"median":-17.643003,"eighty":-13.15152,"marketCap":5302891486},{"date":"2023-08-11","current":-8.126006,"twenty":-27.98738,"median":-17.643003,"eighty":-13.113949,"marketCap":5089808802},{"date":"2023-08-18","current":-7.991704,"twenty":-27.98738,"median":-17.559252,"eighty":-13.079069,"marketCap":4943068484},{"date":"2023-08-25","current":-8.752256,"twenty":-27.98738,"median":-17.442018,"eighty":-13.009616,"marketCap":5390036119},{"date":"2023-09-01","current":-8.935936,"twenty":-27.98738,"median":-17.392059,"eighty":-12.978786,"marketCap":5510914158},{"date":"2023-09-08","current":-8.898728,"twenty":-27.98738,"median":-17.374511,"eighty":-12.956615,"marketCap":5796523666},{"date":"2023-09-15","current":-8.952406,"twenty":-27.98738,"median":-17.311127,"eighty":-12.879471,"marketCap":5812828146},{"date":"2023-09-22","current":-8.26667,"twenty":-27.98738,"median":-17.213144,"eighty":-12.821376,"marketCap":5365860511},{"date":"2023-09-29","current":-8.299648,"twenty":-27.98738,"median":-17.137339,"eighty":-12.786988,"marketCap":5338311562},{"date":"2023-10-06","current":-7.942079,"twenty":-27.98738,"median":-17.064875,"eighty":-12.70048,"marketCap":5090038308},{"date":"2023-10-13","current":-8.19916,"twenty":-27.98738,"median":-17.034448,"eighty":-12.637686,"marketCap":5265888332},{"date":"2023-10-20","current":-7.897341,"twenty":-27.98738,"median":-16.950238,"eighty":-12.506327,"marketCap":5084383966},{"date":"2023-10-27","current":-7.850435,"twenty":-27.996999,"median":-16.897477,"eighty":-12.433541,"marketCap":5032364024},{"date":"2023-11-03","current":-7.812981,"twenty":-27.996999,"median":-16.795286,"eighty":-12.356383,"marketCap":5048761614},{"date":"2023-11-10","current":-8.072859,"twenty":-27.996999,"median":-16.751159,"eighty":-12.27544,"marketCap":5205952311},{"date":"2023-11-17","current":-8.084953,"twenty":-27.996999,"median":-16.679308,"eighty":-12.105765,"marketCap":5286809396},{"date":"2023-11-24","current":-7.945324,"twenty":-27.996999,"median":-16.679308,"eighty":-11.643956,"marketCap":5215901091},{"date":"2023-12-01","current":-8.649846,"twenty":-27.996999,"median":-16.628942,"eighty":-11.389165,"marketCap":5679021537},{"date":"2023-12-08","current":-9.472938,"twenty":-27.993793,"median":-16.54651,"eighty":-11.216927,"marketCap":6152320454},{"date":"2023-12-15","current":-10.265212,"twenty":-27.993793,"median":-16.50434,"eighty":-11.097597,"marketCap":6794419113},{"date":"2023-12-22","current":-10.411937,"twenty":-27.993793,"median":-16.401961,"eighty":-10.980071,"marketCap":6890019549},{"date":"2023-12-29","current":-10.804649,"twenty":-27.996999,"median":-16.362158,"eighty":-10.877852,"marketCap":7204539324},{"date":"2024-01-05","current":-10.618051,"twenty":-28.003343,"median":-16.262519,"eighty":-10.812319,"marketCap":7004853208},{"date":"2024-01-12","current":-11.62417,"twenty":-28.003343,"median":-16.212397,"eighty":-10.812319,"marketCap":7661045546},{"date":"2024-01-19","current":-11.501354,"twenty":-28.009687,"median":-16.10121,"eighty":-10.810401,"marketCap":7522453198},{"date":"2024-01-26","current":-11.423448,"twenty":-28.003343,"median":-16.034045,"eighty":-10.812319,"marketCap":7452874183},{"date":"2024-02-02","current":-12.26812,"twenty":-28.003343,"median":-15.892322,"eighty":-10.812319,"marketCap":8011769037},{"date":"2024-02-09","current":-15.212102,"twenty":-28.003343,"median":-15.772088,"eighty":-10.812319,"marketCap":7883553111},{"date":"2024-02-16","current":-16.08924,"twenty":-28.003343,"median":-15.748423,"eighty":-10.812319,"marketCap":8333637472},{"date":"2024-02-23","current":-17.198545,"twenty":-28.003343,"median":-15.748423,"eighty":-10.812319,"marketCap":8956395707},{"date":"2024-03-01","current":-16.073996,"twenty":-27.996999,"median":-15.749583,"eighty":-10.814236,"marketCap":8365341527},{"date":"2024-03-08","current":-15.739262,"twenty":-27.914563,"median":-15.739262,"eighty":-10.814236,"marketCap":8281552237},{"date":"2024-03-15","current":-16.182326,"twenty":-27.847417,"median":-15.739262,"eighty":-10.814236,"marketCap":8485930167},{"date":"2024-03-22","current":-15.831004,"twenty":-27.761701,"median":-15.716255,"eighty":-10.814236,"marketCap":8276456943},{"date":"2024-03-28","current":-16.307757,"twenty":-27.731992,"median":-15.715626,"eighty":-10.814236,"marketCap":8480579820},{"date":"2024-04-05","current":-16.129857,"twenty":-27.647462,"median":-15.714838,"eighty":-10.812319,"marketCap":8435446042},{"date":"2024-04-12","current":-16.73499,"twenty":-27.583364,"median":-15.714838,"eighty":-10.812319,"marketCap":8629121369},{"date":"2024-04-19","current":-15.678934,"twenty":-27.500617,"median":-15.714023,"eighty":-10.812319,"marketCap":8049238014},{"date":"2024-04-26","current":-15.168374,"twenty":-27.442493,"median":-15.711287,"eighty":-10.814236,"marketCap":7822997809},{"date":"2024-05-03","current":-15.022563,"twenty":-27.394574,"median":-15.643642,"eighty":-10.814236,"marketCap":8061235601},{"date":"2024-05-10","current":-14.073933,"twenty":-27.308275,"median":-15.618754,"eighty":-10.814236,"marketCap":7605898622},{"date":"2024-05-17","current":-12.91619,"twenty":-27.226828,"median":-15.534997,"eighty":-10.814236,"marketCap":7041682209},{"date":"2024-05-24","current":-13.672901,"twenty":-27.153912,"median":-15.477149,"eighty":-10.814236,"marketCap":7422761264},{"date":"2024-05-31","current":-14.49229,"twenty":-27.094752,"median":-15.463474,"eighty":-10.814236,"marketCap":7882096228},{"date":"2024-06-07","current":-14.552327,"twenty":-26.958863,"median":-15.410909,"eighty":-10.814236,"marketCap":7942308676},{"date":"2024-06-14","current":-13.579514,"twenty":-26.88788,"median":-15.356496,"eighty":-10.812319,"marketCap":7331592551},{"date":"2024-06-21","current":-12.977214,"twenty":-26.765804,"median":-15.258303,"eighty":-10.810401,"marketCap":6974877081},{"date":"2024-06-28","current":-14.461515,"twenty":-26.558478,"median":-15.216022,"eighty":-10.804649,"marketCap":7765156691},{"date":"2024-07-05","current":-14.191597,"twenty":-26.533374,"median":-15.190262,"eighty":-10.804649,"marketCap":7695189991},{"date":"2024-07-12","current":-14.27428,"twenty":-26.508986,"median":-15.120186,"eighty":-10.804649,"marketCap":7782935115},{"date":"2024-07-15","current":-14.465145,"twenty":-26.431235,"median":-15.089268,"eighty":-10.804649,"marketCap":7918854032},{"date":"2024-08-02","current":-14.47449,"twenty":-26.176901,"median":-15.006461,"eighty":-10.749788,"marketCap":7829961913},{"date":"2024-08-09","current":-13.203321,"twenty":-26.078777,"median":-14.955173,"eighty":-10.749788,"marketCap":7224922008},{"date":"2024-08-16","current":-14.52139,"twenty":-25.747893,"median":-14.900226,"eighty":-10.749788,"marketCap":8000290683},{"date":"2024-08-23","current":-14.348966,"twenty":-25.537053,"median":-14.816192,"eighty":-10.749788,"marketCap":7993982210},{"date":"2024-08-30","current":-14.239132,"twenty":-25.376377,"median":-14.761401,"eighty":-10.749788,"marketCap":7910825066},{"date":"2024-09-06","current":-12.575294,"twenty":-25.204444,"median":-14.709505,"eighty":-10.749788,"marketCap":6824620726},{"date":"2024-09-13","current":-12.082843,"twenty":-24.965218,"median":-14.685047,"eighty":-10.749788,"marketCap":6526975502},{"date":"2024-09-20","current":-16.138372,"twenty":-24.89955,"median":-14.677518,"eighty":-10.749788,"marketCap":8799277548},{"date":"2024-09-27","current":-16.065853,"twenty":-24.697036,"median":-14.677518,"eighty":-10.749788,"marketCap":8790088396},{"date":"2024-10-04","current":-15.593724,"twenty":-24.697036,"median":-14.677518,"eighty":-10.749788,"marketCap":8407729095},{"date":"2024-10-11","current":-14.536324,"twenty":-24.697036,"median":-14.673982,"eighty":-10.749788,"marketCap":7774241454},{"date":"2024-10-18","current":-14.279832,"twenty":-24.697036,"median":-14.62122,"eighty":-10.749788,"marketCap":7569254037},{"date":"2024-10-25","current":-14.671416,"twenty":-24.615282,"median":-14.597641,"eighty":-10.749788,"marketCap":7757499341},{"date":"2024-10-31","current":-13.807171,"twenty":-24.38359,"median":-14.567264,"eighty":-10.749788,"marketCap":7338578839},{"date":"2024-11-08","current":-14.323048,"twenty":-24.067565,"median":-14.547159,"eighty":-10.745536,"marketCap":7562680391},{"date":"2024-11-15","current":-14.340744,"twenty":-22.828564,"median":-14.538333,"eighty":-10.745536,"marketCap":7427024251},{"date":"2024-11-22","current":-16.381869,"twenty":-21.818062,"median":-14.538333,"eighty":-10.745536,"marketCap":7329017172},{"date":"2024-11-29","current":-18.074176,"twenty":-21.511458,"median":-14.538333,"eighty":-10.745536,"marketCap":8132197137},{"date":"2024-12-06","current":-17.508257,"twenty":-21.254954,"median":-14.538333,"eighty":-10.745536,"marketCap":7892557876},{"date":"2024-12-13","current":-17.452314,"twenty":-20.923585,"median":-14.538333,"eighty":-10.745536,"marketCap":7807100484},{"date":"2024-12-20","current":-18.589951,"twenty":-20.700227,"median":-14.538333,"eighty":-10.745536,"marketCap":8231399424},{"date":"2024-12-27","current":-18.877828,"twenty":-20.554656,"median":-14.538333,"eighty":-10.745536,"marketCap":8384983688},{"date":"2025-01-03","current":-18.855148,"twenty":-20.394227,"median":-14.538333,"eighty":-10.745536,"marketCap":8246937132},{"date":"2025-01-10","current":-18.297678,"twenty":-20.164444,"median":-14.537794,"eighty":-10.741285,"marketCap":8033592454},{"date":"2025-01-17","current":-17.915201,"twenty":-19.885961,"median":-14.537794,"eighty":-10.741285,"marketCap":7865665690},{"date":"2025-01-24","current":-17.171929,"twenty":-19.868162,"median":-14.537794,"eighty":-10.741285,"marketCap":7624890939},{"date":"2025-01-31","current":-17.124916,"twenty":-19.576677,"median":-14.537794,"eighty":-10.741285,"marketCap":7613527466},{"date":"2025-02-07","current":-16.897094,"twenty":-19.381495,"median":-14.537794,"eighty":-10.741285,"marketCap":7477165780},{"date":"2025-02-14","current":-21.582035,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":8522007294},{"date":"2025-02-21","current":-23.380772,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9250623688},{"date":"2025-02-28","current":-23.293859,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9164448904},{"date":"2025-03-07","current":-22.14423,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9066903836},{"date":"2025-03-14","current":-22.191243,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9114778716},{"date":"2025-03-21","current":-23.812142,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9768869264},{"date":"2025-03-28","current":-23.159015,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9451698184},{"date":"2025-04-04","current":-21.461559,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":8981925924},{"date":"2025-04-11","current":-20.283953,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":8577383188},{"date":"2025-04-17","current":-22.013296,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9464265340},{"date":"2025-04-25","current":-22.471506,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9647004585},{"date":"2025-05-02","current":-26.133782,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10069079824},{"date":"2025-05-09","current":-24.978649,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9622933758},{"date":"2025-05-16","current":-24.886372,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9511242765},{"date":"2025-05-23","current":-25.065112,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9662780275},{"date":"2025-05-30","current":-25.437176,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9875295030},{"date":"2025-06-06","current":-27.397906,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10719316700},{"date":"2025-06-13","current":-26.093952,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10319040329},{"date":"2025-06-20","current":-26.303205,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10306361892},{"date":"2025-06-27","current":-26.122714,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10441598554},{"date":"2025-07-03","current":-26.245325,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10547366785},{"date":"2025-07-11","current":-26.7623,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10687247467},{"date":"2025-07-18","current":-27.099217,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10730241097},{"date":"2025-07-25","current":-25.342939,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10191912410},{"date":"2025-08-01","current":-26.88084,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10506189788},{"date":"2025-08-08","current":-29.005669,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11526531562},{"date":"2025-08-15","current":-36.809961,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11628868512},{"date":"2025-08-22","current":-37.076196,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11674889862},{"date":"2025-08-29","current":-37.131841,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11741499711},{"date":"2025-09-05","current":-38.012682,"twenty":-19.10408,"median":-14.536665,"eighty":-10.740548,"marketCap":11997644857},{"date":"2025-09-12","current":-37.58893,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11969789829},{"date":"2025-09-19","current":-37.774178,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12072732322},{"date":"2025-09-26","current":-36.292828,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11489593373},{"date":"2025-10-03","current":-38.360079,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12169619375},{"date":"2025-10-10","current":-41.851033,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":13122050964},{"date":"2025-10-17","current":-39.969585,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12649151236},{"date":"2025-10-24","current":-39.020231,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12281340337},{"date":"2025-10-31","current":-39.695833,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12446305358},{"date":"2025-11-07","current":-38.922391,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12175640527},{"date":"2025-11-14","current":-39.959951,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12613714306},{"date":"2025-11-21","current":-47.63087,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12803118589},{"date":"2025-11-28","current":-48.017721,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12972971463},{"date":"2025-12-05","current":-46.912541,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12743853378},{"date":"2025-12-12","current":-46.898582,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12840388464},{"date":"2025-12-19","current":-44.628604,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12207411568},{"date":"2025-12-26","current":-47.378311,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13002298578},{"date":"2026-01-02","current":-47.619463,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13028570785},{"date":"2026-01-09","current":-47.200634,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12813148688},{"date":"2026-01-16","current":-48.809861,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13199231109},{"date":"2026-01-23","current":-51.278492,"twenty":-19.2008,"median":-14.537005,"eighty":-10.740794,"marketCap":14034617713},{"date":"2026-01-30","current":-49.457294,"twenty":-19.473274,"median":-14.537005,"eighty":-10.740794,"marketCap":13746130054},{"date":"2026-02-06","current":-48.579171,"twenty":-19.873914,"median":-14.537005,"eighty":-10.740794,"marketCap":13342861135},{"date":"2026-02-13","current":-49.47185,"twenty":-20.78029,"median":-14.537005,"eighty":-10.740794,"marketCap":13387046047},{"date":"2026-02-20","current":-52.664929,"twenty":-21.348455,"median":-14.537005,"eighty":-10.740794,"marketCap":14130361625},{"date":"2026-02-27","current":-52.256391,"twenty":-21.767802,"median":-14.537005,"eighty":-10.740794,"marketCap":14055477644},{"date":"2026-03-06","current":-55.25027,"twenty":-22.145732,"median":-14.537005,"eighty":-10.740794,"marketCap":14568617053},{"date":"2026-03-13","current":-53.475323,"twenty":-22.286208,"median":-14.537005,"eighty":-10.740794,"marketCap":14056705251},{"date":"2026-03-20","current":-52.239326,"twenty":-22.799748,"median":-14.537005,"eighty":-10.740794,"marketCap":13738141431},{"date":"2026-03-27","current":-51.481844,"twenty":-22.965697,"median":-14.542677,"eighty":-10.740794,"marketCap":13540496827},{"date":"2026-04-02","current":-53.215656,"twenty":-23.210618,"median":-14.552327,"eighty":-10.740794,"marketCap":14009442410},{"date":"2026-04-10","current":-55.976492,"twenty":-23.521125,"median":-14.601916,"eighty":-10.740794,"marketCap":14932783372},{"date":"2026-04-17","current":-55.895061,"twenty":-23.977541,"median":-14.651537,"eighty":-10.740794,"marketCap":15009390262},{"date":"2026-04-24","current":-52.039647,"twenty":-24.443036,"median":-14.677146,"eighty":-10.740794,"marketCap":13900443750},{"date":"2026-05-01","current":-52.971898,"twenty":-24.761358,"median":-14.689835,"eighty":-10.740794,"marketCap":14171039055},{"date":"2026-05-08","current":26.050831,"twenty":-24.985695,"median":-14.691154,"eighty":-10.719303,"marketCap":15206467665},{"date":"2026-05-15","current":26.339893,"twenty":-24.985695,"median":-14.691154,"eighty":-10.61616,"marketCap":15247775456},{"date":"2026-05-22","current":26.755021,"twenty":-24.985695,"median":-14.691154,"eighty":-10.569295,"marketCap":15373240878},{"date":"2026-05-29","current":25.521023,"twenty":-24.989218,"median":-14.691246,"eighty":-10.512934,"marketCap":14749640464},{"date":"2026-06-05","current":23.576405,"twenty":-24.985695,"median":-14.691154,"eighty":-10.411293,"marketCap":13592501449},{"date":"2026-06-12","current":23.432565,"twenty":-24.985695,"median":-14.691154,"eighty":-10.343667,"marketCap":13391259882},{"date":"2026-06-18","current":25.223947,"twenty":-24.985695,"median":-14.689835,"eighty":-10.26867,"marketCap":14357095184},{"date":"2026-06-26","current":28.777183,"twenty":-24.989218,"median":-14.670745,"eighty":-10.194686,"marketCap":16247151020},{"date":"2026-07-02","current":29.306086,"twenty":-24.989218,"median":-14.660805,"eighty":-10.130811,"marketCap":16632864025},{"date":"2026-07-10","current":30.176679,"twenty":-24.989218,"median":-14.660805,"eighty":-10.056663,"marketCap":17107396610},{"date":"2026-07-17","current":28.441447,"twenty":-24.989218,"median":-14.660805,"eighty":-9.991084,"marketCap":16136592381},{"date":"2026-07-24","current":29.539224,"twenty":-24.989218,"median":-14.660805,"eighty":-9.900049,"marketCap":16656528385},{"date":"2026-07-31","current":28.989544,"twenty":-24.992741,"median":-14.670073,"eighty":-9.837464,"marketCap":16551708152},{"date":"2026-08-07","current":28.822108,"twenty":-24.992741,"median":-14.670073,"eighty":-9.751029,"marketCap":16471280048},{"date":"2026-08-14","current":18.969052,"twenty":-24.992741,"median":-14.670073,"eighty":-9.598109,"marketCap":16232632725},{"date":"2026-08-21","current":19.316044,"twenty":-24.992741,"median":-14.670073,"eighty":-9.49927,"marketCap":16734209496},{"date":"2026-08-28","current":18.951474,"twenty":-24.992741,"median":-14.645114,"eighty":-9.402009,"marketCap":16376290098}],"updateTime":1788232950105},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASND\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647559020","title":"Ascendis Pharma reports new radiographic data from Week 104 from ApproaCH Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559020?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:15","pubTimestamp":1782825335,"startTime":"0","endTime":"0","summary":"Ascendis Pharma (ASND) announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP in child...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-reports-new-radiographic-data-from-week-104-from-approach-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-reports-new-radiographic-data-from-week-104-from-approach-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASND","LU0889565916.HKD","BK4139","LU0320765992.SGD","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555774","title":"Ascendis Says Transcon CNP Achondroplasia Trial Shows Continued Leg-alignment Gains at Week 104","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555774","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647555774?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:32","pubTimestamp":1782822737,"startTime":"0","endTime":"0","summary":"Ascendis says TransCon CNP achondroplasia trial shows continued leg-alignment gains at Week 104Ascendis Pharma disclosed 2-year data from its completed pivotal ApproaCH trial; results were presented a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL5p7BZs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU0889565916.HKD","LU2210150020.SGD","ASND","LU0314104364.USD","LU0109394709.USD","BK4139","SG9999014005.SGD","LU0320765992.SGD","NDAQ","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2095319765.USD","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646360316","title":"Ascendis Pharma Added to Multiple Russell Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2646360316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646360316?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:11","pubTimestamp":1782504701,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S (ASND) said Friday it has been added to the Russell 3000, Russell 1000, Russell 2500 and Russell Midcap indexes as part of the 2026 Russell US Indexes semi-annual reconstitution, effective after the close of US markets on June 26.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU0109394709.USD","BK4585","BK4139","LU0320765992.SGD","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646853713","title":"Ascendis Pharma Reports Week 104 Approach Trial Data Showing Improved Leg Alignment with Transcon CNP in Achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2646853713","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646853713?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417693,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reports Week 104 ApproaCH trial data showing improved leg alignment with TransCon CNP in achondroplasiaAscendis Pharma will present new follow-up data on its once-weekly TransCon CNP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL6PDvD3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","ASND","IE00BN0W2T93.GBP","LU0889565916.HKD","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU0320765992.SGD","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU0109394709.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124872966","title":"Movement Alert｜Ascendis Pharma Rises 8.3% in Regular Trading, Core Drug Long-Term Clinical Data Impresses as Analysts Reiterate Bullish Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1124872966","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124872966?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:16","pubTimestamp":1782404194,"startTime":"0","endTime":"0","summary":"On June 25, Ascendis Pharma rose 8.3% in regular trading, trading at approximately $259.16/share, with turnover of $327 million. The rally was driven by the market continuing to digest strong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031007","title":"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031007?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:50","pubTimestamp":1781769052,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND) and Corbus Pharmaceuticals (C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4139","BK4581","BK4585","BK4137","LU0320765992.SGD","ASND","XBI","LU0109394709.USD","BK4588","CRBP","LABU","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644210607","title":"Ascendis Pharma sells priority review voucher for $187.5 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2644210607","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644210607?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:48","pubTimestamp":1781729318,"startTime":"0","endTime":"0","summary":"Ascendis Pharma completed the sale of its Rare Pediatric Disease Priority Review Voucher to an undisclosed buyer for USD 187.5 million cash.Transaction closed June 17, 2026; proceeds reported before transaction-related expenses.The voucher was awarded by the FDA following the February 2026 approval of YUVIWEL .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL383ftf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0320765992.SGD","ASND","BK4139","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644881748","title":"Ascendis Pharma (ASND) Receives a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2644881748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644881748?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:35","pubTimestamp":1781692553,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Derek Archila maintained a Buy rating on Ascendis Pharma today and set a price target of $326.00. Archila covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ascendis-pharma-asnd-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ascendis-pharma-asnd-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU0640476718.USD","LU0310800379.SGD","LU1201861249.SGD","LU0154236417.USD","LU0052756011.USD","LU1668664300.SGD","LU0868494708.USD","BK4139","LU1069347547.HKD","LABU","LU0211327993.USD","BK4504","LU0708994859.HKD","LU0868494617.USD","LU0128525689.USD","LU0942090050.USD","LU0289960550.SGD","IE00B19Z3581.USD","LU0971096721.USD","XLV","LU0162691827.USD","LU0251131958.USD","LU0683600562.USD","IE000M9KFDE8.USD","LU0320765489.SGD","LU2236285917.USD","IE0002270589.USD","LU0889565916.HKD","BK4582","LU0980610538.SGD","LU0417517546.SGD","LU1267930573.SGD","LU0130517989.USD","LU0149725797.USD","LU0251142724.SGD","LU0477156953.USD","PGF","LU0072461881.USD","BK4581","LU0742534661.SGD","LU0310799852.SGD","XBI","LU2461242641.AUD","LU0267386448.USD","LU1267930227.SGD","LU0208291251.USD","LU1035773651.USD","LU2361045086.USD","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643757879","title":"Analysts’ Top Healthcare Picks: Amylyx Pharmaceuticals Inc (AMLX), Ascendis Pharma (ASND)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643757879","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643757879?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:40","pubTimestamp":1781613612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), Ascendis Pharma (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-amylyx-pharmaceuticals-inc-amlx-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-amylyx-pharmaceuticals-inc-amlx-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4585","BK4137","LU0109394709.USD","LU0029874061.USD","LU0128526141.USD","LU0889565916.HKD","XLV","BK4007","BK4139","XBI","AMLX","BK4588","ASND","LABU","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643048092","title":"Ascendis Pharma's Yorvipath Has Superior Profile Relative to Competitors, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2643048092","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643048092?lang=en_us&edition=fundamental","pubTime":"2026-06-15 22:54","pubTimestamp":1781535244,"startTime":"0","endTime":"0","summary":"Ascendis Pharma's  Yorvipath hypoparathyroidism therapy maintains a superior clinical profile compared with competing programs, Wedbush analysts said in a Monday note.The company's 3.5-year data from the phase-3 PaTHway study and the 5-year data from the phase-2 PaTH Forward study of Yorvipath in hypoparathyroidism provide strong evidence for sustained clinical benefit from long-term treatment, analysts said.Wedbush said that both studies showed high retention rates, durable efficacy, and continued improvement in renal function with longer treatment.Quality of life improvement, which is now required by the FDA for approvals, is the strongest evidence for Yorvipath's efficacy, a key opinion leader said, according to analysts.Wedbush has an outperform rating and a $273 price target on the stock.Price: 223.74, Change: +5.68, Percent Change: +2.60","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASND","SPN","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643272180","title":"Ascendis reports sustained efficacy, safety for TransCon PTH in PaTHway hypoparathyroidism trial at Week 182","url":"https://stock-news.laohu8.com/highlight/detail?id=2643272180","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643272180?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:15","pubTimestamp":1781518506,"startTime":"0","endTime":"0","summary":"The update showed sustained long-term disease control, with most patients maintaining normal mineral balance while reducing reliance on conventional supplements.Patient-reported symptoms and quality of life remained improved over the multi-year follow-up.The safety profile stayed consistent over time, with no new safety concerns reported.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL1Df1ft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4139","ASND","LU0109394709.USD","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643732247","title":"Ascendis Pharma completes Phase 3 PaTHway Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643732247","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643732247?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:40","pubTimestamp":1781469605,"startTime":"0","endTime":"0","summary":"Ascendis Pharma (ASND) announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH demonstr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-completes-phase-3-pathway-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-completes-phase-3-pathway-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","ASND","BK4139","LU0109394709.USD","BK4585","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643210484","title":"Ascendis says Phase 3 PaTHway trial shows TransCon PTH sustains hypoparathyroidism benefits through Week 182","url":"https://stock-news.laohu8.com/highlight/detail?id=2643210484","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643210484?lang=en_us&edition=fundamental","pubTime":"2026-06-14 04:00","pubTimestamp":1781380818,"startTime":"0","endTime":"0","summary":"Long-term treatment sustained symptom relief, improved quality of life, normalized key disease markers, reduced reliance on conventional supplements.Data indicated durable kidney benefits, stable bone health, no new safety signals through three-and-a-half years of follow-up.Trial retention stayed high, supporting feasibility for chronic use in a long-duration endocrine indication.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDL1qdxrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","ASND","SG9999014005.SGD","IE00B64PRP62.GBP","LU0320765992.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","LU0889565916.HKD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643210776","title":"Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2643210776","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643210776?lang=en_us&edition=fundamental","pubTime":"2026-06-14 04:00","pubTimestamp":1781380800,"startTime":"0","endTime":"0","summary":"Multi-organ system and quality-of-life benefits sustained through three and a half years86% response rate for the multi-component endpoint 89% of patients completed the three-and-a-half-year trial COP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/13/3311416/0/en/Phase-3-Data-Show-TransCon-PTH-Replicated-Systemic-Actions-of-Endogenous-PTH-Through-Week-182-in-Adults-with-Hypoparathyroidism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","ASND","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643529266","title":"MBX's Flagship Drug Trial Met Expectations But Perhaps Some Investors Wanted More -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2643529266","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643529266?lang=en_us&edition=fundamental","pubTime":"2026-06-13 01:21","pubTimestamp":1781284860,"startTime":"0","endTime":"0","summary":"Copyright (c) 2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISBC","MBX","LU0889565916.HKD","BK4211","BK4139","LU0320765992.SGD","ASND","BK4585","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642990182","title":"European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2642990182","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642990182?lang=en_us&edition=fundamental","pubTime":"2026-06-12 23:14","pubTimestamp":1781277272,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.53% to 1,917.29 on the S&P Europe Select ADR Index, which is up more than 2% for t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","ASND","DBVT","BK4139","AKTX","DAVA","BK4141","BK4585","BK4613","BK4117","LU0889565916.HKD","AUTL","LU1829250122.USD","IE00B3T34201.USD","LU2236285917.USD","BK4505","SNN","AZNH","SAP","BK4007","TRIB","EVAX","IEUR","LU0648005311.SGD","EPV","LU2462157665.USD","BK4020","AZN","BK4023","LU2237443465.HKD","LU2237443978.SGD","BK4547","BK4107","LU2456880835.USD","FOCL","BK4134","IE00BMPRXN33.USD","MREO","SQNS","TRVG","BK4528","AFG","DAVA.AU","IE00BMPRXR70.SGD","LNOK","LU0058720904.USD","LU0109394709.USD","LU0289739699.SGD","NOK","SLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642231629","title":"Ascendis says Phase 2 trial shows TransCon PTH sustains hypoparathyroidism benefits at 5 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2642231629","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642231629?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:01","pubTimestamp":1781208081,"startTime":"0","endTime":"0","summary":"Results showed sustained long-term control of the disease, supporting reduced reliance on standard supplements while maintaining stable calcium management.Patients reported durable improvements in symptoms and day-to-day functioning, with quality-of-life measures staying near normal ranges.Renal and skeletal outcomes remained favorable over time, supporting the drug’s aim to restore more normal hormone biology.Safety remained consistent over five years, with no new safety signals reported and high treatment completion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL3cVxRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","NDAQ","LU2095319765.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU0889565916.HKD","LU2210150020.SGD","ASND","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642923191","title":"5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2642923191","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642923191?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:01","pubTimestamp":1781208060,"startTime":"0","endTime":"0","summary":"– Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint  – 95% of patients completed five years of treatment CO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310783/0/en/5-Year-Phase-2-Data-Show-TransCon-PTH-Replicated-Systemic-Actions-of-Endogenous-PTH-in-Adults-with-Hypoparathyroidism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND","LU0320765992.SGD","LU0889565916.HKD","BK4139","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642673184","title":"Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642673184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642673184?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:42","pubTimestamp":1781005327,"startTime":"0","endTime":"0","summary":"Oppenheimer believes Ascendis Pharma (ASND) is oversold following a development in the ongoing ITC investigation into Yuviwel initiated by BioMarin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-oversold-following-itc-development-says-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-oversold-following-itc-development-says-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASND","BK4139","OPY","BK4127","LU0109394709.USD","BK4585","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434173","title":"Ascendis presents final Phase 3 PaTHway results for palopegteriparatide in adult hypoparathyroidism at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434173","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434173?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:00","pubTimestamp":1780952445,"startTime":"0","endTime":"0","summary":"Ascendis flagged new long-term safety and efficacy results for TransCon PTH in adult hypoparathyroidism for presentation at ENDO 2026 in Chicago.Final Phase 3 PaTHway readout is set for June 13, positioning the program with mature evidence for potential commercial execution.A Phase 2 COACH update due June 15 is expected to show sustained benefit for combining TransCon CNP with TransCon hGH in children with achondroplasia.Additional ENDO posters are slated to reinforce durability of benefit in hypoparathyroidism and real-world performance of lonapegsomatropin in pediatric growth hormone deficiency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief on June 0","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDLbR8tgT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","LU0320765992.SGD","ASND","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":150,"code":"91000000","status":"200"}]}}